Research
Education
Healthcare
Community
About
Oct 26, 2026 | UC Irvine News
$23 Million from Cary and Will Singleton will Support, Equip New Home for UCI MIND
A $23 million gift from Cary and Will Singleton will help the University of California, Irvine accelerate the search for new ways to understand, treat and, ultimately, prevent Alzheimer’s disease and related dementias.
Oct 22, 2026 | UC Irvine Charlie Dunlop School of Biological Sciences
Common Cholesterol Drugs Show Promise Against Chemotherapy-Resistant Pancreatic Cancer
Pancreatic cancer can become harder to treat when tumors stop responding to chemotherapy, leaving patients and families with few options. UC Irvine researchers have identified a weakness that emerges as cancer cells resist a widely used chemotherapeutic, pointing to a possible new use for cholesterol-lowering statins.
Sep 22, 2026 | UC Irvine School of Medicine
Lbachir BenMohamed, PhD, Receives $3.2 Million NIH Grant to Develop Immunotherapy Against Recurrent Ocular Herpes
“Our goal is to develop a safe and durable immunotherapy that can reduce potentially blinding recurrent herpetic disease, limit transmission and ultimately improve the lives of millions of people worldwide,” says Lbachir BenMohamed, PhD.
Matt Miller Director mrmille2@uci.edu
Communications & PR Office
Stay Connected
Nearly 190 clinicians, researchers, music therapists, artists and students gathered at UC Irvine on Oct. 28–29, 2026, for HARMONICS 2026: The International Conference on Music, Medicine & Science.
In a recent podcast episode, UCI Health orthopaedic spine surgeon Hao-Hua Wu, MD, shares his journey from early global health experiences in Malawi and Tanzania to founding the Global Spine Research Initiative (GSRI).
A recent study by UC Irvine researchers identifies a potential biomarker for predicting a tumor’s drug response, moving us one step closer to personalized cancer treatment.
Nov 04, 2026 | Everyday Health
5 Signs Your Tardive Dyskinesia Treatment Is Working for You
Studies have shown that people who take medications like deutetrabenazine for TD experience a decrease in symptoms compared with those who don't take the drugs. “For me, the most important question is whether there has been a meaningful change from where the patient started,” says Dr. Sanaz Attaripour Isfahani, a neurologist who specializes in the diagnosis and treatment of movement disorders at UCI Health in Orange, California.
Oct 29, 2026 | Everyday Health
Treatment-Resistant Hypertension: What It Means When Nothing Seems to Work
Shaista Malik, MD, PhD, MPH, professor of medicine in the Mary & Steve Wen Cardiovascular Division at UC Irvine School of Medicine, discusses underlying causes of treatment-resistant hypertension, including hormonal imbalances, and shares insights on medications, nutrition and lifestyle factors that influence blood pressure.
